retatrutide 1 month results Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial Retatrutide Not Working? 21 Reasons

Eur J Endocrinol 179(1):111

BMI Qualifications for GLP-1 Treatments To qualify for GLP-1 medications through Hormone Fitness, patients typically need to meet specific Body Mass Index (BMI) criteria: BMI of 30 or higher: Individuals classified as obese

For now, semaglutide is the practical option, while Retatrutide may become an alternative once larger trials confirm its safety and effectiveness

In the era of personalized medicine, single-cell sequencing at genetic and epigenetic levels may contribute to a better understating of the pathogenicity of T2DM and its treatment

This holistic approach underscores our commitment to enhancing both the health and confidence of our patients

Complementing its insulinotropic effects, GLP-1 also suppresses the release of glucagon, slows gastric emptying and intestinal motility, and induces feelings of satiety 5